Illexcor Holdings, LLC
BiotechnologyBiopharmaceuticals
Henrico, PA
2023
founded
About
Illexcor Therapeutics, LLC is a biopharmaceutical company dedicated to innovating treatments for sickle cell disease (SCD). Founded in 2020, the company has a mission to address the urgent unmet medical needs by developing oral therapies that effectively manage SCD on a global level.
Company Values
Illexcor stands out by focusing on first-in-class oral therapies that directly target the underlying causes of sickle cell disease, offering a potentially more accessible alternative to invasive treatments like bone marrow transplants.